GSK plc (GSK) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript

GSK plc ( GSK ) Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum September 23, 2026 3:50 PM EDT Company Participants Kaivan Khavandi - SVP, R&D Head of Respiratory, Immu. & Infl. and Global Head of GSK Translational & Dev. Conference Call Participants Courtney Breen - Bernstein Institutional Services LLC, Research Division Presentation Courtney Breen Bernstein Institutional Services LLC, Research Division Hi, everyone. Thank you so much for being with us here today. My name is Courtney Breen. I am the U.S. biopharma analyst here at Bernstein. I am thrilled to be sharing the stage today with Kaivan Khavandi. He is the SVP and Global Head of Translational and Development Sciences at GSK. I know you have a focus and is responsible -- and are responsible for respiratory, for hepatology, for immunology, inflammation. Question-and-Answer Session Courtney Breen Bernstein Institutional Services LLC, Research Division Can you give us a little bit of context about the scope of your role and the things that you focus on in the company because it sounds quite vast? Kaivan Khavandi SVP, R&D Head of Respiratory, Immu. & Infl. and Global Head of GSK Translational & Dev. Yes. Great. Well, first of all, Courtney, thanks for having me. So the role, I guess, has 2 aspects. One is the end-to-end accountability for R&D for respiratory, immunology and inflammation. So that's a fully integrated unit from discovery, target choice through to translation, clinical development, asset leadership through to product approval. So the full life cycle of assets, as you described, it currently represents a lot of activity through to the late stage in respiratory medicine and hepatology, but also, I think, some very promising programs in what we're increasingly thinking of just as comorbid disease that's the consequence of chronic inflammatory pathology. The other hat